Company Information

  

Address: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
BALLYCOOLIN 
City: DUBLIN 
State:  
Zip Code: 15 
Telephone: 636-449-1830 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

(Dollar amounts in thousands, except per-share amounts and as otherwise noted) General Overview Avadel Pharmaceuticals plc ("Avadel," the "Company," "we," "our," or "us") is a branded specialty pharmaceutical company. Avadel's current revenues are primarily derived from products we market based on first-to-file New Drug Applications ("NDAs") for pharmaceutical products previously sold in the U.S. without Food and Drug Administration ("FDA") approval ("Unapproved Marketed Products" or "UMDs"). In addition, through the acquisition of patient-focused, innovative products or businesses in the commercial- and or late-stage of development, Avadel seeks to provide solutions for overlooked and unmet medical needs, including our urology product, Noctiva(TM), which we in-licensed in 2017 and will begin marketing in 2018. Avadel also seeks to develop products that utilize our Micropump® drug delivery technology, such as our narcolepsy product which is in clinical trials.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
03/20180.70NA10.41
12/20171.63NA5.03
09/20171.93NA5.44
06/20170.92NA11.99
03/2017-0.24NAN/E
12/2016-1.00NAN/E
09/20160.62NA20.00

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity0.18Total Liab/Total Assets0.66
Net Inc/Total Assets0.27Total Liab/Inv Cap1.01
Net Inc/Inv Cap0.41Total Liab/Comm Equity0.45
Pretax Inc/Net Sales0.53Interest Coverage Ratio89.08
Net Inc/Net Sales0.39Curr Debt/Equity0.00
Cash Flow/Net Sales0.10LTD/Equity0.00
SG&A/NetSales0.16Total Debt/Equity0.00
Asset Utilization   Liquidity  
Net Receivables Turnover10.62Quick Ratio1.36
Inventory Turnover3.46Current Ratio1.43
Inventory Day Sales0.01Net Rec/Curr Assets0.12
Net Sales/Work Cap4.63Inv/Curr Assets0.05
Net Sales/PP&E57.73  

Income Statement (Millions)

  3/31/2018 12/31/2017 9/30/2017 6/30/2017
Total Revenues(Net Sales) 33.29 34.75 39.68 46.31
Cost of Goods Sold 6.59 4.05 3.79 4.56
Selling & Admin Exps 27.46 22.12 1.66 -0.80
Operating Income -12.63 -4.08 26.12 34.13
Interest Exp 1.60 0.26 0.26 0.26
Pretax Income -14.56 -5.69 27.60 36.30
Other Income -0.34 -1.34 1.75 2.43
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -12.24 -8.25 21.68 28.93

Balance Sheet (Millions)

Assets 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Cash & Short Term Investments 198.18 94.08 115.61 173.80
Receivables - Total 16.68 14.79 24.08 19.29
Inventories - Total 5.95 6.16 5.87 5.75
Total Current Assets 231.93 123.98 148.93 204.35
Net Property, Plant & Equipment 2.72 3.00 3.18 3.33
Total Assets 351.86 253.28 277.43 259.16
Liabilities        
Accounts Payable 61.85 58.82 63.59 44.12
Debt in Current Liabilities 0.11 0.11 0.30 0.29
Total Current Liabilities 87.19 86.54 97.31 88.71
Long-Term Debt 111.72 0.16 0.61 0.59
Total Liabilities 264.81 167.70 180.96 182.43
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.42 0.41 0.41 0.41
Retained Earnings -274.92 -262.69 -254.44 -276.12
Treasury Stock -42.57 -22.36 -17.51 -14.34
Total Stockholders' Equity 87.05 85.58 96.46 76.73
Total Liabilities and Stockholders' Equity 351.86 253.28 277.43 259.16

Cash Flow Summary (Millions)

Categories 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Net Cash Provided by Operating Activities -18.01 -13.82 -3.06 8.23
Net Cash Provided by Investing Activities -80.74 -0.53 1.08 15.75
Net Cash Provided by Financing Activities 122.92 -6.03 -3.93 -12.95

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20134.18-42.92--
12/201414.98-85.47--
12/2015173.0141.80--
12/2016150.25-41.28-1.00
12/2017173.2468.271.63
Growth Rates153.74----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/189425,57963.81




Report Date : 7/16/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.